Work

Abstract PD10-11: Differential Benefit to Elacestrant in A Large Cohort of ER+ HER2- Breast Cancer: Impact of ESR1 Mutants and Prior Therapy

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-pd10-11

Authors: G. Sledge, H. McArthur, J. Xiu, M. J. Oberley, M. Su, M. Radovich, D. Spetzler, V. Kaklamani

Institutions: Caris Life Sciences (United States), The University of Texas Southwestern Medical Center, The University of Texas at San Antonio Health Science Center

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129303380

Cites:

Cited by:

Related to: